Email Newsletters

Life Sciences

WPI To Host Biotech Corporate Forum

Worcester Polytechnic Institute's Bioengineering Institute will present the sixth annual Biotechnology and Bioengineering Corporate Forum on March...

Life Sciences Center Seeks Projects

The Massachusetts Life Sciences Center is looking for capital improvement projects that it can spend up to...

Mass., Israel Unite For R&D

Gov. Deval Patrick has signed a Memorandum of Understanding with the nation of Israel designed to encourage...

ACT Treatment Moves Toward Orphan Status

Marlborough's Advanced Cell Technology Inc. has taken a step toward receiving orphan drug designation in Europe for...
ADVERTISEMENT

Locals On State Overseas Trip

Gov. Deval Patrick is heading to Israel and the United Kingdom this week, and so are several...

Genzyme Board Backs Stock Sale

Genzyme Corp. moved one step closer to being acquired by French drug maker Sanofi-Aventis as its board...

RXi Announces Pricing For Offering

Worcester-based RXi Pharmaceuticals has priced its public offering of common stock and warrants at $1.35 per unit...

Genzyme Sells Pharmaceuticals Segment

Cambridge-based Genzyme Corp., which has operations in Central Massachusetts, has completed the sale of its pharmaceutical intermediates...
ADVERTISEMENT

Harvard Bioscience Profits Down, Revenues Up

Holliston life sciences tools company Harvard Bioscience saw its profits fall 42 percent to $2.2 million for...

ACT Gets Embryo Technique Patent

Advanced Cell Technology Inc. of Marlborough has patented its "embryo-safe" technique for deriving human embryonic stem cell...
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA